HOMEVULNERABILITIESCVE-2024-49839
CRITICAL

CVE-2024-49839

CWE-126Published: February 3, 2025· Updated: Jun 17, 2026

9.8
CVSS v3.1

Official Description

Memory corruption during management frame processing due to mismatch in T2LM info element.

NVD Source

Technical Analysis

CVE-2024-49839 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 9.8.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected Vendors & Products

Qualcomm372 product(s)
ar8035 firmwarear8035csr8811 firmwarecsr8811fastconnect 6700 firmwarefastconnect 6700fastconnect 6900 firmwarefastconnect 6900fastconnect 7800 firmwarefastconnect 7800immersive home 214 firmwareimmersive home 214+360
Source: NVD CPE · 372 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (1)

Quick Facts

CVE IDCVE-2024-49839
CVSS Score9.8 / 10
SeverityCRITICAL
WeaknessCWE-126
CISA KEVNo
Affected1 vendor(s)
PublishedFeb 3, 2025

Related CVEs (CWE-126)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2024-49839 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.